Jubilant issues NCDs of Rs 495 crore
DSIJ Intelligence / 27 Jan 2017
Jubilant Life Sciences, the integrated global pharmaceuticals and life sciences company, has completed issuance of its secured rated listed redeemable non-convertible debentures (NCDs) aggregating to Rs 495 crore for cash at par on a private placement basis.
Jubilant Life Sciences, the integrated global pharmaceuticals and life sciences company, has completed issuance of its secured rated listed redeemable non-convertible debentures (NCDs) aggregating to Rs 495 crore for cash at par on a private placement basis. The company will utilise the proceeds from the NCDs for refinancing of its existing debt.
The issue comprises of 4 STRRPs payable in the second, third, fourth and fifth years such that the overall yield on the entire transaction is equivalent to 8.65 per cent per annum, payable semi-annually.
India Ratings and Research Pvt Ltd has rated the NCDs as IND AA-/Stable. Yes Bank was the sole arranger of the NCD issue.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.